← Back to Clinical Trials
Recruiting NCT06837025

NCT06837025 Fascial Manipulation in Cerebral Palsy Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06837025
Status Recruiting
Phase —
Sponsor Orton Orthopaedic Hospital
Condition Cerebral Palsy (CP)
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2024-10-04
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 14 Years
Study Type INTERVENTIONAL
Interventions
Fascial manipulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2024-10-04 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the study is to investigate the potential additional benefits of a relatively new physiotherapy method, fascial manipulation, in the rehabilitation of movement difficulties or other problems caused by CP (cerebral palsy). A physiotherapist specialized in fascial manipulation specifically treats the muscle fascia, which plays a central role in the problems associated with CP. Fascial manipulation feels just like a massage but does not hurt. The purpose of the study is to determine how physiotherapeutic rehabilitation methods should be further developed in Finland and elsewhere. Fascial manipulation was originally developed in Italy and is used to treat many musculoskeletal problems. There have been few studies on the effectiveness of fascial manipulation in the context of CP problems. It is important to obtain more research evidence, which is why conducting this study is crucial.

Eligibility Criteria

Inclusion Criteria: * Age 7-14 years * GMFCS level 2-3 * Good cooperation * Family living in the Helsinki metropolitan area Exclusion Criteria: * The child has previously received fascia manipulation by a Stecco-trained therapist or other fascia treatment (if done within the last 6 months) * Surgeries on the lower limbs (if done within the last 12 months) * Electrical stimulation treatments (if done within the last 3 months) * Botox treatments on the lower limbs (if done within the last 6 months) * Reduced cognitive level * Severe visual impairment (unable to perform the walking test) * Other illnesses: psychological or other serious illness

Contact & Investigator

Central Contact

Juha-Pekka Kulmala, PhD

✉ juha-pekka.kulmala@hus.fi

📞 +358404863595

Frequently Asked Questions

Who can join the NCT06837025 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 14 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06837025 currently recruiting?

Yes, NCT06837025 is actively recruiting participants. Contact the research team at juha-pekka.kulmala@hus.fi for enrollment information.

Where is the NCT06837025 trial being conducted?

This trial is being conducted at Helsinki, Finland.

Who is sponsoring the NCT06837025 clinical trial?

NCT06837025 is sponsored by Orton Orthopaedic Hospital. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology